Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Zhiying Shen, Guolin Tan, Zhuqing Zhong, Siqing Ding & Fang Wang. (2019) Interactive Network Platform Improves Compliance and Efficacy of Subcutaneous Immunotherapy for Patients with Allergic Rhinitis. Patient Preference and Adherence 13, pages 2101-2110.
Read now
Read now
Constantinos Pitsios & Nikolas Dietis. (2019) Ways to increase adherence to allergen immunotherapy. Current Medical Research and Opinion 35:6, pages 1027-1031.
Read now
Read now
Jianbin Mao, Kim A. Heithoff, Eleena Koep, Thomas Murphy & Eva Hammerby. (2019) Cost of subcutaneous immunotherapy in a large insured population in the United States. Current Medical Research and Opinion 35:2, pages 351-358.
Read now
Read now
Ilaria Baiardini, Silviya Novakova, Stefan Mihaicuta, Ipek Kivilcim Oguzulgen & Giorgio Walter Canonica. (2019) Adherence to treatment in allergic respiratory diseases. Expert Review of Respiratory Medicine 13:1, pages 53-62.
Read now
Read now
Articles from other publishers (27)
Christoph Owenier, Cornelia Barnowski, Margret Leineweber, Donghui Yu, Marjan Verhagen & Andreas Distler. (2023) Tolerability and Safety of Sublingual Immunotherapy in Patients with Tree Pollen Allergy in Daily Practice—An Open, Prospective, Non-Interventional Study. Journal of Clinical Medicine 12:17, pages 5517.
Crossref
Crossref
Marco Contoli, Celeste Porsbjerg, Sarah Buchs, Julie Rask Larsen, Nick Freemantle & Benedikt Fritzsching. (2023) Real-world, long-term effectiveness of allergy immunotherapy in allergic rhinitis: Subgroup analyses of the REACT study. Journal of Allergy and Clinical Immunology 152:2, pages 445-452.e4.
Crossref
Crossref
Erminia Ridolo, Francesca Nicoletta, Alessandro Barone, Martina Ottoni, Gianenrico Senna & Giorgio Walter Canonica. (2023) Causes of Non-Adherence to Allergen-Specific Immunotherapy: A Foundation towards a Patient-Personalized Approach. Journal of Personalized Medicine 13:8, pages 1206.
Crossref
Crossref
Giulia Brindisi, Alessandra Gori, Caterina Anania, Ivana Martinelli, Martina Capponi, Giovanna De Castro & Anna Maria Zicari. (2023) Subcutaneous Immunotherapy (SCIT) with the New Polymerized Molecular Allergoid Alt a1: A Pilot Study in Children with Allergic Rhinitis Sensitized to Alternaria Alternata. Journal of Clinical Medicine 12:13, pages 4327.
Crossref
Crossref
Michelle Park, Shrey Kapoor, Julie Yi, Nanki Hura & Sandra Y. Lin. (2022) Sublingual immunotherapy persistence and adherence in real‐world settings: A systematic review. International Forum of Allergy & Rhinology 13:5, pages 924-941.
Crossref
Crossref
Michelle J. Park, Shrey Kapoor, Julie Yi, Nanki Hura & Sandra Y. Lin. (2022) Systematic review of real‐world persistence and adherence in subcutaneous allergen immunotherapy. International Forum of Allergy & Rhinology 13:3, pages 255-264.
Crossref
Crossref
Caroline Beutner, Jochen Schmitt, Margitta Worm, Martin Wagenmann, Christian Albus & Timo Buhl. (2023) Lack of Harmonized Adherence Criteria in Allergen Immunotherapy Prevents Comparison of Dosing and Application Strategies: A Scoping Review. The Journal of Allergy and Clinical Immunology: In Practice 11:2, pages 439-448.e6.
Crossref
Crossref
S. Mohana Karthikeyan & G. N. Nikisha. (2020) Efficacy and Safety of Diethylcarbamazine in Treatment of Allergic Rhinitis: A Double Blind Randomised Controlled Trial. Indian Journal of Otolaryngology and Head & Neck Surgery 74:S2, pages 1169-1177.
Crossref
Crossref
Désirée Larenas-Linnemann. (2022) Long-term adherence strategies for allergen immunotherapy. Allergy and Asthma Proceedings 43:4, pages 299-304.
Crossref
Crossref
Ilaria Mormile, Francescopaolo Granata, Aikaterini Detoraki, Daniela Pacella, Francesca Della Casa, Felicia De Rosa, Antonio Romano, Amato de Paulis & Francesca Wanda Rossi. (2022) Predictive Response to Immunotherapy Score: A Useful Tool for Identifying Eligible Patients for Allergen Immunotherapy. Biomedicines 10:5, pages 971.
Crossref
Crossref
Juan Liu, Xian Feng, Huan Wang & Hongmeng Yu. (2021) Compliance with subcutaneous immunotherapy and factors affecting compliance among patients with allergic rhinitis. American Journal of Otolaryngology 42:5, pages 103125.
Crossref
Crossref
Michael T. Werner & John V. Bosso. (2021) Intralymphatic immunotherapy for allergic rhinitis: A systematic review and meta-analysis. Allergy and Asthma Proceedings 42:4, pages 283-292.
Crossref
Crossref
Nanki Hura, Sophia SongRebecca J. KamilGerdline PierreSandra Y. Lin. (2020) Predictors of Completion of Sublingual Immunotherapy. The Laryngoscope 131:7.
Crossref
Crossref
Erika Jensen-Jarolim, Franziska Roth-Walter, Galateja Jordakieva & Isabella Pali-Schöll. (2021) Allergens and Adjuvants in Allergen Immunotherapy for Immune Activation, Tolerance, and Resilience. The Journal of Allergy and Clinical Immunology: In Practice 9:5, pages 1780-1789.
Crossref
Crossref
Fei Ma, Yuan-Yi Zhang, Gui Yang, Li-Hua Mo, Da-Bo Liu, Li-Teng Yang, Zhi-Gang Liu, Yan Ning & Ping-Chang Yang. (2021) Integrin αvβ6 cooperates with resiquimod to restore antigen-specific immune tolerance in airway allergy. Immunology Letters 230, pages 49-58.
Crossref
Crossref
Mao Jin, Lei Zhang, Guojin Zhou, Shoude Zhang, Xuan Li & Sunhong Hu. (2020) The effect of the standard length of the first prescription on the adherence to sublingual immunotherapy for patients with allergic rhinitis. International Forum of Allergy & Rhinology 10:6, pages 768-772.
Crossref
Crossref
Litty Johnson, Albert Duschl & Martin Himly. (2020) Nanotechnology-Based Vaccines for Allergen-Specific Immunotherapy: Potentials and Challenges of Conventional and Novel Adjuvants under Research. Vaccines 8:2, pages 237.
Crossref
Crossref
Cristiano Caruso, Barbara Bramé, Diego Bagnasco, Alessia Cocconcelli, Valeria Ortolani, Valerio Pravettoni, Sergio Scarpa, Giuliana Zisa, Giovanni Passalacqua & Stefania Colantuono. (2020) Adherence to Allergen Subcutaneous Immunotherapy is Increased by a Shortened Build-Up Phase: A Retrospective Study. BioMed Research International 2020, pages 1-4.
Crossref
Crossref
Anne K. Ellis, Charles W. Frankish, Kristen Armstrong, Lisa Steacy, Mark W. Tenn, Stephen Pawsey & Roderick P. Hafner. (2020) Persistence of the clinical effect of grass allergen peptide immunotherapy after the second and third grass pollen seasons. Journal of Allergy and Clinical Immunology 145:2, pages 610-618.e9.
Crossref
Crossref
Khulood M. Sayed, Ahmed G. Kamel & Abdellah H. Ali. (2019) One-year evaluation of clinical and immunological efficacy and safety of sublingual versus subcutaneous allergen immunotherapy in allergic conjunctivitis. Graefe's Archive for Clinical and Experimental Ophthalmology 257:9, pages 1989-1996.
Crossref
Crossref
Emma Shardlow & Christopher Exley. (2019)
The size of micro-crystalline tyrosine (MCT®) influences its recognition and uptake by THP-1 macrophages
in vitro
. RSC Advances 9:42, pages 24505-24518.
Crossref
Crossref
Katherine R. Keefe, Minhtran Ngo-Howard, Michael P. Platt & Christopher D. Brook. (2018) Compliance With Subcutaneous Immunotherapy Appointments in an Urban Tertiary Care Setting. American Journal of Rhinology & Allergy 32:6, pages 473-477.
Crossref
Crossref
Yongshi Yang, Yin Wang, Lin Yang, Jingru Wang, Nan Huang, Xiaolong Wang, Lintao Hu, Qing Jiang, Guanghui Liu & Rongfei Zhu. (2018) Risk factors and strategies in nonadherence with subcutaneous immunotherapy: a real-life study. International Forum of Allergy & Rhinology 8:11, pages 1267-1273.
Crossref
Crossref
Natalija Novak, Timo Buhl & Oliver Pfaar. (2018) Adherence During Early Allergen Immunotherapy and Strategies to Motivate and Support Patients. European Medical Journal, pages 21-29.
Crossref
Crossref
R. Mösges, C. Bachert, P. Panzner, M. A. Calderon, L. Haazen, S. Pirotton, N. Wathelet, S. R. Durham, M.-A. Bonny, T. Legon, R. von Frenckell, O. Pfaar & M. H. Shamji. (2018) Short course of grass allergen peptides immunotherapy over 3 weeks reduces seasonal symptoms in allergic rhinoconjunctivitis with/without asthma: A randomized, multicenter, double-blind, placebo-controlled trial. Allergy 73:9, pages 1842-1850.
Crossref
Crossref
Deborah S. Leuthard, Agathe Duda, Sandra N. Freiberger, Sina Weiss, Isabella Dommann, Gabriele Fenini, Emmanuel Contassot, Matthias F. Kramer, Murray A. Skinner, Thomas M. Kündig, Matthew D. Heath & Pål Johansen. (2018) Microcrystalline Tyrosine and Aluminum as Adjuvants in Allergen-Specific Immunotherapy Protect from IgE-Mediated Reactivity in Mouse Models and Act Independently of Inflammasome and TLR Signaling. The Journal of Immunology 200:9, pages 3151-3159.
Crossref
Crossref
Christopher R. Roxbury & Sandra Y. Lin. (2017) Update on Allergen Immunotherapy for Allergic Rhinitis: Drops, Tablets, or Shots?. Current Otorhinolaryngology Reports 5:3, pages 181-186.
Crossref
Crossref